Back to search

Article

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine in People Living with HIV-1

2021-10-15

Abstract excerpt

Background: It has been proven that inactivated COVID-19 vaccines are safe and effective in general population with intact immunity. However, their safety and immunogenicity have not been demonstrated in people living with HIV (PLWH).<br><br>Methods: 42 HIV-1 infected individuals who were stable on cART and 28 healthy individuals were enrolled in this study. Two doses of an inactivated COVID-19 vaccine (BIBP-CorV)...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b2b97505-04b8-5792-8fe8-f3c585a628ba
DOI
10.2139/ssrn.3943152
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine in People Living with HIV-1DOI 10.2139/ssrn.3943152
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine in people living with HIV-1Semantic proximity
Immunogenicity and Safety of Inactivated SARS-CoV-2 Vaccine in People Living with HIV: A Cross-Sectional StudySemantic proximity
Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIVSemantic proximity
Immunogenicity of SARS-CoV-2 infection and Ad26.CoV2.S vaccination in people living with HIVSemantic proximity
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIVSemantic proximity
SARS-CoV-2 Humoral and Cellular Immune Responses in COVID-19 Convalescent Individuals With HIVSemantic proximity
SARS-CoV-2 Humoral and Cellular Immune Responses in HIV-Positive PatientsSemantic proximity
Immunogenicity and Safety of COVID-19 Booster Vaccination: A Real-World Clinical Trial to Identify the Best Vaccination StratagySemantic proximity
COVID-19 Vaccinations, Infections and Outcomes among 784 People Living with HIVSemantic proximity
An in-depth investigation of the safety and immunogenicity of an inactivated SARS-CoV-2 vaccineSemantic proximity
Antibody response against SARS-CoV-2 spike protein in people with HIV after COVID-19 vaccinationSemantic proximity
High efficacy of VLA2001 vaccine against SARS-CoV-2 infection in non-human primatesSemantic proximity
Select a neighboring publication to make it the new centre.